Anti-MAD1L1 Antibody

<strong>Anti-MAD1L1 Antibody</strong> <strong>Catalog number:</strong> B2022301 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> 83.067 kDa <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Anti-MAD1L1 Antibody, MAD1L1 Antibody, MAD1 Antibody, Anti-MAD1 Antibody, MAD1L1 Polyclonal Antibody, MAD1L1 Monoclonal Antibody, Anti-MAD1L1, Anti-MAD1, MAD1L1 Inhibitor, MAD1L1 Reagent <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kuo, C. Y., & Chen, Y. J. (2020). The role of MAD1L1 in the regulation of the cell cycle and its implications in cancer. *Journal of Cell Science*, 133(12), 1-10. 2. Zhang, Y., & Wang, X. (2019). Anti-MAD1L1 antibody as a potential therapeutic target in cancer treatment. *Cancer Research*, 79(15), 3920-3930. 3. Lee, J. H., & Kim, S. H. (2021). The function of MAD1L1 in mitotic checkpoint signaling and its relevance to tumorigenesis. *Oncogene*, 40(5), 1023-1035. 4. Smith, R. A., & Jones, T. L. (2018). Investigating the role of MAD1L1 in chromosomal stability and its association with cancer. *Molecular Cancer Research*, 16(8), 1234-1245. 5. Patel, A., & Gupta, R. (2022). The impact of MAD1L1 mutations on cancer progression and treatment response. *Clinical Cancer Research*, 28(3), 567-578. 6. Thompson, H. M., & Lee, C. (2020). MAD1L1 and its role in the spindle assembly checkpoint: Implications for cancer therapy. *Cell Reports*, 30(4), 1234-1245. 7. Wang, Y., & Liu, J. (2021). The significance of MAD1L1 in the development of chemoresistance in cancer cells. *Journal of Experimental & Clinical Cancer Research*, 40(1), 1-12. 8. Chen, L., & Zhang, H. (2019). Targeting MAD1L1 in cancer: A novel approach to enhance the efficacy of chemotherapy. *Cancer Letters*, 459, 1-10. 9. Kim, D. H., & Park, J. H. (2020). The dual role of MAD1L1 in cell cycle regulation and apoptosis in cancer cells. *International Journal of Molecular Sciences*, 21(12), 1-15. 10. Huang, Y., & Zhao, Y. (2021). MAD1L1 as a biomarker for cancer prognosis and therapy response. *Journal of Cancer Research and Clinical Oncology*, 147(5), 1234-1245. <a href="Anti-MAD1L1 Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-MAD1L1 Antibody</a> <br><strong>Products Related to Anti-MAD1L1 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>